tiprankstipranks
Trending News
More News >
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Income Statement

Compare
604 Followers

Cue Biopharma Income Statement

Last quarter (Q1 2025), Cue Biopharma's total revenue was $421.00K, a decrease of -75.48% from the same quarter last year. In Q1, Cue Biopharma's net income was $-12.26M. See Cue Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.29M$ 5.49M$ 1.25M$ 14.94M$ 3.15M
Gross Profit
$ 9.29M$ -32.61M$ -560.83K$ 16.72M$ -30.39M
Operating Expenses
$ 50.79M$ 19.54M$ 54.75M$ 58.65M$ 48.20M
Depreciation and Amortization
$ 2.35M$ 3.44M$ 1.81M$ -1.78M$ 1.06M
EBITDA
$ -37.53M$ -46.05M$ -50.49M$ -45.44M$ -43.99M
Operating Income
$ -41.50M$ -52.15M$ -53.22M$ -43.71M$ -45.04M
Other Income/Expenses
$ 826.00K$ 1.42M$ 215.00K$ 45.90K$ 463.91K
Pretax Income
$ -40.67M$ -50.73M$ -53.01M$ -43.67M$ -44.58M
Net Income
$ -40.67M$ -50.73M$ -52.80M$ -44.16M$ -44.78M
Per Share Metrics
Basic EPS
$ -0.72$ -1.11$ -1.48$ -1.41$ -1.56
Diluted EPS
$ -0.72$ -1.11$ -1.48$ -1.41$ -1.56
Weighted Average Shares Outstanding
56.33M 45.75M 35.65M 31.29M 28.69M
Weighted Average Shares Outstanding (Diluted)
56.33M 45.75M 35.65M 31.29M 28.69M
Currency in USD

Cue Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis